136 related articles for article (PubMed ID: 12353858)
1. Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients.
Shafran I; Piromalli C; Decker JW; Sandoval J; Naser SA; El-Zaatari FA
Dig Dis Sci; 2002 Sep; 47(9):2079-81. PubMed ID: 12353858
[TBL] [Abstract][Full Text] [Related]
2. Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis.
Naser SA; Hulten K; Shafran I; Graham DY; El-Zaatari FA
Vet Microbiol; 2000 Dec; 77(3-4):497-504. PubMed ID: 11118734
[TBL] [Abstract][Full Text] [Related]
3. Serum antibodies to Mycobacterium avium subspecies paratuberculosis combined with anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients: prevalence and diagnostic role.
Biet F; Gendt L; Anton E; Ballot E; Hugot JP; Johanet C
Dig Dis Sci; 2011 Jun; 56(6):1794-800. PubMed ID: 21221802
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease.
El-Zaatari FA; Naser SA; Hulten K; Burch P; Graham DY
Curr Microbiol; 1999 Aug; 39(2):115-9. PubMed ID: 10398839
[TBL] [Abstract][Full Text] [Related]
5. Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease.
Müller S; Schaffer T; Schoepfer AM; Hilty A; Bodmer T; Seibold F
World J Gastroenterol; 2008 Jun; 14(23):3650-61. PubMed ID: 18595132
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic anti-GP2 and anti-Saccharomyces cerevisiae antibodies in ruminants with paratuberculosis: A better understanding of the immunopathogenesis of Crohn's disease.
Liaskos C; Gkoutzourelas A; Spyrou V; Koutsoumpas A; Athanasiou LV; Amiridis GS; Billinis C; Bogdanos DP
Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):778-785. PubMed ID: 32035824
[TBL] [Abstract][Full Text] [Related]
7. Specific antibodies against recombinant protein of insertion element 900 of Mycobacterium avium subspecies paratuberculosis in Japanese patients with Crohn's disease.
Nakase H; Nishio A; Tamaki H; Matsuura M; Asada M; Chiba T; Okazaki K
Inflamm Bowel Dis; 2006 Jan; 12(1):62-9. PubMed ID: 16374261
[TBL] [Abstract][Full Text] [Related]
8. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
9. An investigation into the relationship between anti-Helicobacter pylori and anti-Saccharomyces cerevisiae antibodies in patients with axial spondyloarthritis and Crohn disease.
Rodrigues IK; Andrigueti M; de Oliveira Gil ID; de Lucca Schiavon L; de Andrade KR; Pereira IA; de Castro GR; Zimmermann AF; Saporiti LN; Bazzo ML; Neves FS
Rheumatol Int; 2015 Feb; 35(2):359-66. PubMed ID: 25119827
[TBL] [Abstract][Full Text] [Related]
10. Targeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease.
Bertin D; Grimaud JC; Lesavre N; Benelmouloud C; Desjeux A; Garcia S; Desplat-Jégo S
PLoS One; 2013; 8(11):e80433. PubMed ID: 24303014
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium avium subsp. paratuberculosis in Crohn's disease is serologically positive.
Naser S; Shafran I; El-Zaatari F
Clin Diagn Lab Immunol; 1999 Mar; 6(2):282. PubMed ID: 10189224
[No Abstract] [Full Text] [Related]
13. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease.
Duarte-Silva M; Afonso PC; de Souza PR; Peghini BC; Rodrigues-Júnior V; de Barros Cardoso CR
Autoimmunity; 2019 Feb; 52(1):37-47. PubMed ID: 30884988
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
[TBL] [Abstract][Full Text] [Related]
15. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease.
Shafran I; Kugler L; El-Zaatari FA; Naser SA; Sandoval J
Dig Liver Dis; 2002 Jan; 34(1):22-8. PubMed ID: 11930899
[TBL] [Abstract][Full Text] [Related]
16. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
[TBL] [Abstract][Full Text] [Related]
17. Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease.
Van Kemseke C; Belaïche J; Steeman C; Louis E
Acta Gastroenterol Belg; 2003; 66(1):1-6. PubMed ID: 12812142
[TBL] [Abstract][Full Text] [Related]
18. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
[TBL] [Abstract][Full Text] [Related]
19. Baker's yeast (Saccharomyces cerevisiae) antigen in obese and normal weight subjects.
Salamati S; Martins C; Kulseng B
Clin Obes; 2015 Feb; 5(1):42-7. PubMed ID: 25611585
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of antibodies anti-saccharomyces cerevisiae (ASCA) and autoantibodies in patients with inflammatory bowel disease].
Beltrão M; Bodas A; Azevedo F; Nunes A; Santos C; Delgado L
Acta Med Port; 2010; 23(5):829-36. PubMed ID: 21144323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
